WHOLE-BODY POSITRON EMISSION TOMOGRAPHY IN BREAST-CANCER

Authors
NITZSCHE EU HOH CK DALBOHM NM GLASPY JA PHELPS ME MOSER EA HAWKINS RA
Citation
Eu. Nitzsche et al., WHOLE-BODY POSITRON EMISSION TOMOGRAPHY IN BREAST-CANCER, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 158(4), 1993, pp. 293-298
Citations number
21
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren → ACNP
ISSN journal
09366652
Volume
158
Issue
4
Year of publication
1993
Pages
293 - 298
Database
ISI
SICI code
0936-6652(1993)158:4<293:WPETIB>2.0.ZU;2-H
Abstract
The value of whole body positron emission tomography using F-18 2-deox y-2-fluoro-d-glucose in primary work-up and follow-up was prospectivel y evaluated in 37 patients with primary or metastatic breast cancer. F rom 20 primary breast masses 15 from 16 malignant and 4 from 4 benign lesions confirmed by biopsy, were detected. In 3 out of 21 patients in correlation to morphologic imaging, respectively biopsy, no metastati c disease was not identified. Generally speaking, whole body positron emission tomography appears to be a suitable diagnostic staging tool i n breast cancer.